| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |